GERN

0.87074.63%
AE

Ahmed ElNawawi

Executive VP & Chief Commercial Officer

Mr. Ahmed ElNawawi is Executive VP & Chief Commercial Officer of Geron Corporation from October 20, 2025. He served as Senior Vice President and U.S. Commercial Head at Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, where he led the U.S. commercial organization spanning the sales, marketing, market access, commercial excellence and data analytics functions. During his tenure, he successfully built the U.S. business from the ground up expanding the team from 30 to 165 employees and delivering three consecutive years of topline and bottom-line growth. He oversaw the U.S. launch of ORSERDU in metastatic breast cancer, which was recognized as one of the top oncology launches in recent years, as well as drove renewed growth for ELZONRIS in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Before joining Stemline, he spent nearly two decades at Novartis Oncology in global, regional and country leadership roles across the U.S., Europe and the Middle East. His experience includes leading country P&L organizations, launching multiple oncology and hematology brands and driving cultural and organizational transformation. He received an MBA from the University of Leicester and a B.S. in Clinical Pharmacy from Ain Shams University in Cairo, Egypt.

Positions